All Articles

To commemorate the tenth anniversary of AONN+, leadership takes a look back at 10 of the association’s most significant accomplishments.

November 11, 2019 — Oncology News & Updates

FDA Updates, In the News

Web Exclusives

FDA Approves Ziextenzo, Third Biosimilar to Pegfilgrastim for Febrile Neutropenia
Trump Will Nominate Dr Hahn as Next FDA Commissioner
Researchers Report High Rates of E-Cigarette Use Among Children and Teens

November 4, 2019 — Oncology News & Updates

Financial Toxicity, In the News

Web Exclusives

Xospata Extends Overall Survival in Patients with FLT3 Mutation–Positive Relapsed or Refractory Acute Myeloid Leukemia
Published Results from KEYNOTE-048 Trial Show Extended Survival with Keytruda in Advanced Head and Neck Cancers
Discussing Costs of Genomic Testing with Patients

October 28, 2019 – Oncology News & Updates

FDA Updates, In the News, Ovarian Cancer

Web Exclusives

Zejula Now Approved for Late-Line Ovarian Cancer
Trump Set to Nominate Hahn as FDA Commissioner
FDA Aims to Improve Breast Implant Guidance

Evaluating Effectiveness of the Memorial Hermann LDCT Program Using 4-Year Retrospective Data

By Carolyn Allsen, BSN, RN, OCN, ONN-CG; Krystie Fenton, BSN, RN, OCN; Tam Huynh, MSN, RN, FNP-C, CBCN, AOCNP; Carol Kirton, BSN, RN, OCN, ONN-CG; Shirley Ruiz, BSN, RN, OCN, ONN-CG, CBCN; Elizabeth Traje, BSN, RN, ACM, OCN, ONN-CG; Angela Sisk, MSN, RN, OCN, AHN-BC

Community Outreach and Prevention, AONN+ Conference Abstracts

November 2019 Vol 10, No 11

Lung cancer is the leading cause of death in men and women in the United States, with an estimated 228,150 new cases diagnosed, and 142,670 deaths.

AONN+ Celebrates 10 Years of Accomplishments!

By Lillie D. Shockney, RN, BS, MAS, HON-ONN-CG

Letters from Lillie

November 2019 Vol 10, No 11

I am simply thrilled to write to you today in acknowledgment of the 10th anniversary of the Academy of Oncology Nurse & Patient Navigators (AONN+)! We have made tremendous progress over the past decade in promoting navigation as an integral part of a successful cancer care team. This progress is in no small part due to the outstanding contributions from our members, committees, and Leadership Council.

Health Center Patient Navigation as a Catalyst for Cancer Screening Quality Improvement

By Megan Loucks, MS; Inna Scurtu, BS, OPN-CG; Marquita Iddirisu, MS

Community Outreach and Prevention, AONN+ Conference Abstracts

November 2019 Vol 10, No 11

Cancer continues to present a major challenge in the Washington, DC, metro area.

Increasing Community Members’ Knowledge and Awareness on How to Understand and Perform the Correct Technique for Self-Breast Exams

By Dana Stevens, BSN, RN, MSHA, CBCN, CN-BN, ONN-CG; Stacey Contreras, CRT(M)

Community Outreach and Prevention, AONN+ Conference Abstracts

November 2019 Vol 10, No 11

Invasive breast cancer is the most common cancer in females, accounting for approximately one-third of all invasive cancers diagnosed annually in the Greater Bay Area and in the state.

Navigation-Driven Lung Cancer Screening Program

By Shawn Perkins, BSN, RN, OCN

Community Outreach and Prevention, AONN+ Conference Abstracts

November 2019 Vol 10, No 11

Lung cancer is the leading cause of cancer death, with 81% of lung cancer diagnoses directly linked to smoking.

Need for Increased Community Outreach for Low-Dose CT Lung Screening in Northwest Arizona/Southeast Nevada

By Michelle Bigg, RN-BSN

Community Outreach and Prevention, AONN+ Conference Abstracts

November 2019 Vol 10, No 11

Sunrise Hospital is a tertiary medical center for rural outlying regions including northwest Arizona and southeast Nevada (NW-AZ/SE-NV).